PM Society NHS Partnerships Interest Group - Mark Wilkinson: Improving Patient Outcomes Through Innovation and Collaboration
1 like1,137 views
The document discusses the importance of innovation and collaboration in the NHS, emphasizing the need for strong partnerships between local businesses and healthcare providers to enhance patient care and reduce variation in service delivery. It outlines strategies for product development in the pharmaceutical industry, the role of clinicians in value assessment, and highlights case studies demonstrating successful collaboration. Additionally, it addresses challenges faced by clinical commissioning groups (CCGs) in federating to achieve strategic change and improving healthcare outcomes.
PM Society NHS Partnerships Interest Group - Mark Wilkinson: Improving Patient Outcomes Through Innovation and Collaboration
- 1. PM Society NHS Partnerships Group Mark Wilkinson - Director Life Sciences Innovation, Interim Chief Officer (Darlington CCG), Interim Managing Director (Durham Dales Easington and Sedgefield CCG) 18 April 2012
- 2. Innovation and Collaboration • Look out not up. 1 • Local business to 2 business relationship. • „Next steps‟ we can take. 3
- 4. The old paradigm? Product development - Industry Value Implementation assessment – – clinicians and NHS bodies HTA bodies and regulators
- 5. Evidence shows us we innovate together Skills for innovation Organisational factors 1st Creativity 1st Attract and retain qualified 2nd Ability to collaborate people 2nd R&D investment 3rd Customer communication 4th Strong supplier relationships Innovation requires collaboration and strong connections to customers / suppliers
- 6. The emerging paradigm? Product development Value Implementation assessment
- 7. Innovation and collaboration 1 • Look out not up.
- 8. Product development Pharma industry led initiative using Tapestry Networks European Healthcare Innovation Leadership Network Clinician led value frameworks for conditions www.tapestrynetworks.com/progress/health care-innovation-case-study.cfm
- 9. NHS quality improvement system Domain 1 Domain 2 Domain 3 Domain 4 Domain 5 Preventing Enhancing Helping people to Ensuring that Treating and caring people from quality of Life recover from people have a for people in a safe dying for people episodes of ill positive environment and with long- health or following experience of protecting them prematurely term injury care from avoidable conditions harm. NICE Quality standards (Building a library of approx 150 over 5 years) Provider payment mechanisms Commissioning Commissioning Outcomes Guidance Standard Tariff CQUIN QOF Framework Contract
- 10. Innovation Health and Wealth Reducing Creating a variation system for Incentives and strengthening innovation investment compliance delivery Developing our High impact Procurement people innovations
- 11. Mike Farrar “I‟m a big fan … principle of clinical commissioning … GPs will micro commission very well, improving individual pathways, and challenging referrals, can they convert small pockets of gain into „right-sizing‟ of the providers? … So the challenge for the CCGs is: can they federate to achieve strategic change? Will they be able to work collaboratively with the NHS Commissioning Board?”
- 12. Drug Reps soften sales pitch – will they still buy the cream cakes? nhsmanagers.net
- 13. Building Trust: Contact ‘The 5 Cs’ Collaboration Clarity Confidence Communication
- 14. Eight industry case studies Industry concerns: • Local restrictions at odds with NICE appraisal or guidance, • Local burdensome administration being introduced with the aim of reducing uptake, • Local reinterpretation of MHRA / NICE appraisal or guidance.
- 15. Observations Little evidence of local discussion on the issues. Lack of information on the uptake of NICE reviewed medicines. Through discussion we shared and improved our knowledge.
- 16. Describing a Business to Trust, Business co-working, Relationship shared vision, integrity Shared value exchange, Understand strategy, Contact at all levels across all functions, Understand needs, do what you say, solve my problems, access, personal contact
- 17. Innovation and collaboration • Look out not up. 1 • Local business to 2 business relationship.
- 18. How it’s happening Products Close Skills and services connections exchange
- 19. St Helens PBC and GSK Higher prevalence / 9% fall in admissions Higher patient satisfaction Higher NICE compliance with less GP variation
- 20. Promoting collaboration • Promoting examples: NHS Networks / Wellards • Avoiding naïve transplantationism • Wider than joint working • Risk shares and value based pricing
- 21. Ten priorities for commissioners • Medication reviews so prescribing standards are met. • Decision-support tools support best practice • Clinicians providing educational info. • Pharmacy technicians support practices • Safe transfer of patient medication information at admission and discharge • Benchmarked information on prescribing performance www.kingsfund.org.uk
- 22. Innovation and collaboration • Look out not up. 1 • Local business to 2 business relationship. • „Next steps‟ we can take. 3 mark.wilkinson@northwest.nhs.uk